These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 26841847

  • 1. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
    Liu N, Xia WY, Liu SS, Chen HY, Sun L, Liu MY, Li LF, Lu HM, Fu YJ, Wang P, Wu H, Gao JX.
    Sci Rep; 2016 Feb 04; 6():20489. PubMed ID: 26841847
    [Abstract] [Full Text] [Related]

  • 2. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
    Ordóñez-Navadijo Á, Fuertes-Yebra E, Acosta-Iborra B, Balsa E, Elorza A, Aragonés J, Landazuri MO.
    Oncogene; 2016 Feb 04; 35(5):587-94. PubMed ID: 25915846
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T, Zhao L, Chen W, Li Z, Hou H, Ding L, Li X.
    Int J Mol Med; 2014 May 04; 33(5):1236-42. PubMed ID: 24549370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression.
    Liu L, Xu H, Zhao H, Sui D.
    J Drug Target; 2021 Mar 04; 29(3):300-309. PubMed ID: 33032456
    [Abstract] [Full Text] [Related]

  • 9. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA, Ashcroft M.
    Cancer Res; 2006 Jun 15; 66(12):6264-70. PubMed ID: 16778202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
    Perier A, Fregni G, Wittnebel S, Gad S, Allard M, Gervois N, Escudier B, Azzarone B, Caignard A.
    Oncogene; 2011 Jun 09; 30(23):2622-32. PubMed ID: 21258414
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J, Ma Y, Jiang H, Zhu H, Liu L, Sun B, Pan S, Krissansen GW, Sun X.
    J Hepatol; 2011 Aug 09; 55(2):359-68. PubMed ID: 21168458
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of hypoxia-specific cytotoxicity of procaspase-3 fused with a VHL-mediated protein destruction motif of HIF-1alpha containing Pro564.
    Harada H, Kizaka-Kondoh S, Hiraoka M.
    FEBS Lett; 2006 Oct 16; 580(24):5718-22. PubMed ID: 17010341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas.
    Pantuck AJ, An J, Liu H, Rettig MB.
    Cancer Res; 2010 Jan 15; 70(2):752-61. PubMed ID: 20068166
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK, Vavilala DT, Prakash S, Mukherji M.
    Biochem Biophys Res Commun; 2013 Aug 16; 438(1):71-7. PubMed ID: 23872148
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway.
    Zhu G, Zhou L, Liu H, Shan Y, Zhang X.
    Cell Physiol Biochem; 2018 Aug 16; 48(4):1735-1746. PubMed ID: 30078003
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.